| Line Item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | |||||||||||
| Cost of revenue | — | — | — | |||||||||||
| Gross margin | — | — | — | |||||||||||
| % of revenue | 29.1% | — | — | — | ||||||||||
| Selling, General and Administrative Expense | ||||||||||||||
| Research and Development Expense | ||||||||||||||
| Non-Operating Income (Expense) | — | |||||||||||||
| Loss from operations | ||||||||||||||
| % of revenue | -7393.7% | — | — | — | ||||||||||
| Other Income | ||||||||||||||
| Accretion of deferred consideration | — | — | — | |||||||||||
| Net loss | ||||||||||||||
| % of revenue | -4720.6% | — | — | — | ||||||||||
| Earnings Per Share (Basic) | ||||||||||||||
| Earnings Per Share (Diluted) |